Artelo Biosciences (ARTL) EBT Growth (3y) (2017 - 2025)
Artelo Biosciences (ARTL) EBT Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 6.22% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.16% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 103.69% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 24.03% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 41.79% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 38.36% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -27.69% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 64.03% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -38.56% |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | 6.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.36% |
| Sep 30, 2025 | -10.02% |
| Jun 30, 2025 | -13.81% |
| Mar 31, 2025 | -6.54% |
| Nov 30, 2021 | -66.08% |
| Aug 31, 2021 | -76.30% |
| May 31, 2021 | -59.10% |
| Feb 28, 2021 | -36.16% |
| Nov 30, 2020 | -73.02% |
| May 31, 2020 | -114.31% |
| Feb 29, 2020 | -372.23% |
| Nov 30, 2019 | -430.11% |
| Aug 31, 2019 | -237.51% |
| May 31, 2019 | -471.23% |
| Feb 28, 2019 | -430.03% |
| Nov 30, 2018 | -231.99% |
| Aug 31, 2018 | -258.61% |
| May 31, 2018 | -353.96% |
| Feb 28, 2018 | -283.90% |
| Nov 30, 2017 | -417.42% |